Dissecting Aneurysm - PowerPoint PPT Presentation

1 / 35
About This Presentation
Title:

Dissecting Aneurysm

Description:

ECHO for Chest Pain. Indications for Echocardiography in Patients ... Coarctation of aorta. Cystic medial necrosis. Congenital Disorders of Connective Tissue ... – PowerPoint PPT presentation

Number of Views:192
Avg rating:3.0/5.0
Slides: 36
Provided by: jimm159
Category:

less

Transcript and Presenter's Notes

Title: Dissecting Aneurysm


1
Dissecting Aneurysm
  • ??? ??
  • Wang, Tzong-Luen,MD, PhD, FACC, FESC

2
ECHO for Chest Pain
  • Indications for Echocardiography in Patients With
    Chest Pain 
  • 1. Diagnosis of underlying cardiac disease in
    patients with chest pain and clinical evidence of
    valvular, pericardial, or primary myocardial
    disease. I
  • 2. Evaluation of chest pain in patients with
    suspected acute myocardial ischemia, when
    baseline ECG is nondiagnostic and when study can
    be obtained during pain or soon after its
    abatement. I
  • 3. Evaluation of chest pain in patients with
    suspected aortic dissection. I
  • 4. Chest pain in patients with severe hemodynamic
    instability. I
  • 5. Evaluation of chest pain for which a
    noncardiac etiology is apparent. III
  • 6. Diagnosis of chest pain in a patient with
    electrocardiographic changes diagnostic of
    myocardial ischemia/infarction. III

3
Epidemiology
  • Proximal almost twice as often as distal
  • Incidence 5 per million per year
  • Overall mortality rate 20-25
  • Hemorrhage and acute heart failure
  • Late complication in survivors rupture of
    postdissection anurysm
  • 10-20
  • More likely if uncontrolled hypertension

4
Risk Factors
  • Inflammatory Diseases of the Aorta
  • Syphilitic aortitis
  • Polyarteritis nodosa
  • Endocarditis
  • Mycotic infections of the aorta
  • Giant cell aortitis
  • SLE
  • Pregnancy
  • Arteriosclerosis
  • Cigarette use
  • Hypertension
  • Congenital Diseases
  • Bicuspid aortic valve
  • Congenital aortic stenosis
  • Coarctation of aorta
  • Cystic medial necrosis
  • Congenital Disorders of Connective Tissue
  • Marfans syndrome
  • Ehlers-Danlos syndrome

5
Clinical Manifestations
  • Cardiovascular
  • Chest Pain (80-90)
  • Severe steady pain
  • Sudden onset
  • Retrosternal if type A
  • Interscapular if type B
  • Migrate to chest, back and epigastrium
  • Hypertension (60-70)
  • Hypotension
  • AR murmur (50 type A)
  • Pericardial friction rub (5)
  • General
  • Hoarseness
  • Syncope

6
Clinical Manifestations
  • Gastrointestinal
  • Abdominal or lumbar pain
  • Nausea
  • Vomiting
  • Extremities
  • Extremity weakness or paralysis
  • Peripheral pulse deficits (40-50)

7
Complications
  • Cardiac tamponade
  • Myocardial infarction
  • CHF
  • Hemothorax
  • Predominantly left
  • Hemoperitoneum
  • Hemispheric stroke
  • 6 of cases
  • Altered mental status
  • Temporary blindness
  • Ischemic myopathy
  • Intestinal ischemia
  • Renal or lower limb ischemia

8
ECG
  • Changes compatible with MI 10-20
  • Positive ECG dose not exclude Dx
  • ST elevation is unusual
  • Negative ECG
  • supporting
  • Signs of preexisting hypertension
  • LVH
  • LV strain
  • Pericarditic changes
  • Diffuse ST elevation
  • PR depression
  • Electrical alternans

9
Pulmonary Embolism
  • ??? ??
  • Wang, Tzong-Luen,MD, PhD, FACC, FESC

10
Clinical Presentation
  • SIGNS and SYMPTOMS
  • Most common
  • Dyspnea
  • Pleuritic chest pain
  • Tachycardia
  • General
  • Apprehension
  • Diaphoresis

11
Clinical Presentation
  • SIGNS and SYMPTOMS
  • Pulmonary
  • Cough
  • Hemoptysis
  • Rales
  • Wheezing
  • Cardiovascular
  • syncope
  • Loud P2
  • S3 or S4 gallop
  • Diaphoresis
  • Cardiac murmures

12
Clinical Presentation
  • SIGNS and SYMPTOMS
  • Cyanosis
  • Extremities
  • Evidence of thrombophlebitis
  • Lower extremity edema

13
Clinical Presentation
  • Mechanism / Description
  • Vast majority arise from thrombi in the deep
    veins of the femur and pelvis
  • Thrombi in the lower extremities occasionally
    propagate to the popliteal veins from where they
    embolize

14
Clinical Presentation
  • Etiology
  • Most patients with pulmonary embolus(PE) have an
    identifiable risk factor

15
Clinical Presentation
  • Etiology
  • Risk factors
  • Recent surgery
  • Pregnancy
  • Cardiac disease
  • Stroke or recent paraplegia
  • Malignancy
  • Age past the fifth decade
  • Previous DVT
  • Immobilization
  • Oral contraceptives
  • Major trauma
  • Factor deficiency state
  • Mutations in factor 5 resulting in activated
    protein C resistance
  • Protein C and S
  • Plasminogen and antithrombin 3 deficiency
  • Antiphospholipid antibody syndrome

16
Clinical Presentation
  • Pediatric Considerations
  • Risk factors for children in decreasing order
    of prevalence
  • Presence of central venous catheter
  • Immobility
  • Heart disease
  • Ventriculoatrial shunt
  • Trauma
  • Neoplasm
  • Surgery
  • Infection
  • Medical Illness
  • Dehydration
  • Shock

17
Pre-Hospital
  • Cautions
  • Initiate supplemental oxygen
  • Establish IV access
  • Cardiac monitor

18
Diagnosis
  • Essential workup
  • CXR
  • To rule out other causes
  • Most common findings with PE
  • Normal
  • Nonspecific pulmonary infiltrates
  • Atelectasis
  • Other findings with PE
  • Pleural effusions
  • Pleural based opacities (When wedged shaped
    called Hampton hump)
  • Elevated hemidiaphragms
  • Local oligemia (Westermarks sign)
  • Enlarged right descending pulmonary artery
    (Pallas sign)

19
Diagnosis
  • ECG
  • To rule out a cardiac etiology
  • Findings in PE
  • Nonspecific ST-T wave changes
  • T-wave inversion in anterior leads
  • Sinus tachycardia
  • Normal ECG
  • Left axis deviation
  • RBBBpattern
  • Atrial fibrillation
  • S1Q3T3 pattern-uncommon and not specific enough
    to rule-in diagnosis of PE

20
Diagnosis
  • ECG
  • Assess oxygenation
  • Pulse oximetry
  • Rapidly attained
  • Arterial blood gases
  • Assesses pO2 and pCO2
  • Do not aid in the diagnosis
  • PE possible with normal Alveolar-arterial gradient

21
Diagnosis
  • Laboratory
  • CBC
  • Anemia may be a contributing factor to dyspnea
  • Very high WBC might suggest infectious etiology
  • d-dimer enzyme-linked immunosorbent assay (ELISA)
  • High sensitivity with low specificity for PE
  • High negative predictive value (gt90)
  • Requires 3-4 hours to perform

22
Diagnosis
  • Imaging / Special tests
  • Ventilation perfusion (V/Q) scan
  • Results reported in probabilities normal, low,
    intermediate, or high probability

23
Diagnosis
  • Imaging / Special tests
  • Ventilation perfusion (V/Q) scan
  • Probability of PE with V/Q results
  • Normal or near normal V/Q scan 4 probability
    for PE
  • Low probability V/Q scan with low clinical
    suspicion 4 probability for a PE
  • Low probability V/Q scan with high clinical
    suspicion 16-40 probability for a PE
  • Intermediate V/Q scan 16-66 probability of PE
  • High probability V/Q scan with low clinical
    suspicion 56 probability of PE
  • High probability V/Q scan with high clinical
    suspicion 96 probability of PE

24
Diagnosis
  • Imaging / Special tests
  • Spiral chest CT with IV contrast
  • Accurate for identifying PE in proximal pulmonary
    vascular tree
  • May be normal with small distal PE
  • Pulmonary angiography
  • Gold standard
  • Use when diagnosis not excluded or confirmed
  • Intermediate probability (10-80) VQ scan
  • Normal CT when distal PE suspected
  • Higher complication rate than other modalities
  • Lower extremity duplex ultrasound
  • Used in patients who would otherwise require
    pulmonary angiography
  • Presence of deep vein thrombosis requires same
    anticlagulation as PE

25
Diagnosis
  • Differential Diagnosis
  • Pneumonia
  • Cardiac dysrhythmias (due to syncope)
  • Asthma
  • Pneumothorax
  • Pleural effusion
  • Pericarditis
  • Myocardial infarction
  • Rib fracture
  • Musculoskeletal pain
  • Pulmonary edema

26
Treatment
  • Initial Stabilization
  • ABCs
  • Provide supplemental oxygen to maintain adequate
    oxygen saturation with nasal cannula or face mask
  • Intubation for if unable to provide adequate
    oxygen
  • Administer IV fluid carefully for hypotensive
    patients
  • Excessive fluid expansion may worsen right heart
    failure

27
Treatment
  • ED Treatment
  • Initiate heparin
  • Prevents additional thrombus from forming
  • Goal is to maintain the PTT between 1.5 and 2.5
    times the control value (60-80 seconds)

28
Treatment
  • ED Treatment
  • Warfarin
  • Begin once a therapeutic PTTis achieved
  • Continue for 5 days with concurrent heparin
    administration
  • Goal is INR of 2-3
  • Thrombolysis
  • Initiate in hemodynamically unstable patients
    with massive PE
  • Stop heparin while infusing TPA
  • Restart heparin when PTT falls in therapeutic
    range (1.5-2.5 times control)

29
Treatment
  • ED Treatment
  • Inferior vena cava (IVC) filter
  • Indicated in patients who cannot tolerate
    anticoagulation and who have been on therapeutic
    anticoagulation but failed
  • Norepinephrine
  • Initiate whith massive PE and hypotension

30
Treatment
  • Medications
  • Heparin options
  • Initial bolus of 80 units/kg IV followed by
    continuous infusion of 18 units/kg/hr
  • Initial bolus of 5,000 units IV followed by 1,280
    units/hr
  • TPA 100 mg IV over 2 hrs
  • Norepinephrine 2-20 µg/min IV
  • Coumadin 5mg loading dose orally each day,
    titrate PT to an INR 2-3

31
Treatment
  • Pediatric Considerations
  • Heparin dosing 50 IU/kg bolus IV followed by
    10-25 IU/kg/hr continuously
  • Thrombolytic dosing
  • TPA 0.1-0.5 mg/kg body weight per hour (use for
    as long as 3days)
  • TPA is not approved by the FDA for use in
    children
  • Streptokinase 3,500-4,000 IU/kg loading dose
    over 30 min followed by 1,000-1,500 IU/kg/hr
  • Urokinase 4,400 IU/kg loading dose over 10 min
    followed by 4,400 IU/kg/hr

32
Disposition
  • Admission Criteria
  • Admit all patients with PE for heparin therapy
  • Cases with a high suspicion for PE, no
    contraindication to anticoagulatoin, and a lack
    of V/Q scanning or angiographic availability may
    be anticoagulated and studied when resources are
    available in the morning or upon transfer
  • Discharge Criteria
  • N/A

33
Miscellaneous
  • ICD 415.1
  • Core content code 16.9

34
Miscellaneous
  • Suggested readings
  • ACCP Consensus Committee on Pulmonary
    Embolism. Opinions regarding the diagnosis and
    management of venous thromboembolic disease.
    Chest 1996109233-37.
  • Becker DM,, Philbrick JT, Bachhuber TL,
    Humphries JE. D-dimer testing and acute venous
    thromboembolism. Arch Intern Med 1996156939-46
  • Evans DA, Wilmott RW. Pulmonary embolism in
    children. Pediatr Clin North Am 199441569-84

35
Miscellaneous
  • Suggested readings
  • Ginsburg JS. Management of venous
    thromboembolism. N Engl J Med 19963351816-28
  • Goldhaber SZ. Pulmonary embolism. N Engl J
    Med 199933993-104
  • PIOPED Investigators. Value of the ventilation
    / perfusion scan in acute pulmonary embolism.
    JAMA 19902632753-59.
  • Trukstra F, Kuijer PM, Van Beek EJ, et al.
    Diagnostic utility of ultrasonography o f leg
    veins in patient suspected of having pulmonary
    embolism. Ann Intern Med 1997126775-81.
  • Author Richard Lenhardt
Write a Comment
User Comments (0)
About PowerShow.com